Up-and-in options are barrier options activated by reaching a price level. They offer unique opportunities for investors to ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Rob Reiner’s son Nick asked A-listers strange questions at Conan O’Brien’s Christmas party hours before the screenwriter allegedly killed his parents. “What’s your name? What’s your last name? Are you ...

On Tuesday, The Wall Street Journal shed some light on what may have prompted the argument. Citing “a person to whom the gathering was described,” Nick interrupted comedian Bill Hader to ask some ...

The Gophers are preparing for the Rate Bowl against New Mexico later this month, but offseason moves are already in full swing. Between player retention, transfer portal recruiting, and coaching staff ...

The clinical-stage biotech might have a successful drug on its hands, if a relatively early-stage clinical trial is any indication. Its REC-4881 did very well in the testing. 10 stocks we like better ...

Before market open, Recursion divulged that its REC-4881 demonstrated notable efficacy in a phase 1b/2 trial. The drug, which treats a disorder called familial adenomatous polyposis (FAP) in which ...

The emotional bombshells from "Sean Combs: The Reckoning" continue until the very end. In the conclusion of Curtis "50 Cent" Jackson's four-part docuseries, which debuted on Netflix Tuesday, Dec. 2, ...